Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The decision by Blue Cross will certainly help tamp down spending for this year
Our liposomal formula solves this problem by enveloping the glutathione in phospholipids
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Below, see a quick list of its available options
US$ 26.60
US$ 26.01
US$ 28.88
